Therapeutic efficacy of once-daily oral administration of a Kunitz-type protease inhibitor, bikunin, in a mouse model and in human cancer.
Therapeutic efficacy of once daily oral administration of a Kunitz-type protease inhibitor bikunin in a mouse model and human cancer.